临床和实验室研究年鉴

  • 国际标准期刊号: 2386-5180
  • 期刊 h 指数: 17
  • 期刊引用分数: 6.26
  • 期刊影响因子: 5.31
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 研究期刊索引目录 (DRJI)
  • 普布隆斯
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
分享此页面

抽象的

A revolutionary approach to drug development and treatment based on pharmacogenomics

Hillin Jiayuan

Pharmacogenomics, the study of how an individual's genetic makeup influences drug response, has revolutionized drug development and treatment approaches. This article explores the profound impact of pharmacogenomics on personalized medicine, highlighting its role in optimizing drug efficacy, minimizing adverse reactions, and guiding treatment decisions based on an individual's genetic profile. By understanding the genetic variations that affect drug metabolism, transport, and targets, researchers and clinicians can tailor drug therapies, improve patient outcomes, and pave the way for precision medicine.